Haizhu Chen

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 22, 2026
Clinical outcomes and genomic landscape of anti-HER2 antibody-drug conjugates in HER2-positive and HER2-low metastatic breast cancer.

|Apr 22, 2026
Focusing on the Advances and Challenges of HER2-Targeted Therapy: Cutting-Edge Breakthroughs in Neoadjuvant Treatment for HER2-Positive Breast Cancer.

|Jan 12, 2026
De-escalation of axillary surgery after neoadjuvant therapy in breast cancer: long-term outcomes of sentinel lymph node biopsy alone versus complete axillary lymph node dissection.

Haizhu Chen, Xiaoyan Qian, Luhui Mao

|Dec 22, 2023
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray.

Liyuan Dai, Haizhu Chen, Qiaoyun Tan

|May 17, 2023
The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.

Ling Lin, Daquan Wang, Haizhu Chen

Pageof 1

Frequent Collaborators

2 joint publications

Herui Yao

1 joint publications

Shasha Wang

1 joint publications

Yuankai Shi

1 joint publications

Xiaohong Han